Meet the 2022 Endocrine Society Laureates: Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS

Ho_Laureate2022

Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS 

Outstanding Scholarly Physician Award

Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS, is emeritus professor at the Garvan Institute, University of New South Wales, and honorary consultant endocrinologist, St. Vincent’s Hospital in Sydney, Australia. 

As a globally recognized pituitary medicine expert and a leader in academic clinical endocrinology, he’s developed therapeutic guidelines and advocated for regulatory agency decisions geared toward improving patient outcomes. He established a gold-standard diagnostic test for growth hormone (GH) deficiency and developed standards for use of GH replacement therapy in adults. 

He’s published over 250 peer-reviewed studies that directly impact clinical practice and is currently an associate editor for the Journal of the Endocrine Society and a member of the Society’s Nominating Committee. 

How has the Endocrine Society supported your professional development/career journey?

The Endocrine Society has been integral to my career development in providing a culture of academic excellence for clinicians and a governance structure of engagement and inclusion.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

Follow your passion guided by the signposts for learning and for achieving clinical and scholarly excellence from a mentor and your Society.

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in